Qsp 1.9 -

| Feature | QSP 1.5 (previous) | QSP 1.9 (current) | |---------|--------------------|--------------------| | Default ODE solvers | CVODE (stiff, slow) | SUNDIALS + GPU-accelerated | | Parameter estimation | Manual, local gradient | Global + Monte Carlo + adjoint sensitivity | | Uncertainty quantification | Bootstrapping | Bayesian inference (Stan/NUTS) | | Model library | Custom-only | FAIR-compliant, versioned | | Clinical covariate handling | None | Age/sex/genetics via virtual populations |

QSP 1.9 was used to simulate alpha-synuclein aggregation under different therapeutic interventions. The model predicted that a specific BACE1 inhibitor would not work in early-stage Parkinson’s—a hypothesis later confirmed by clinical trial data, thus saving millions in failed trials.

QSP 1.9 refers to the ninth major iteration of a proprietary (or open-source) Quantitative Systems Pharmacology software framework or modeling standard. While the term can sometimes be generic, within industry contexts, QSP 1.9 specifically denotes a version that introduces: qsp 1.9

Unlike earlier versions (e.g., QSP 1.6 or 1.8), version 1.9 focuses on interoperability with other pharmacometric tools such as NONMEM, Monolix, and SimBiology. This means that modelers can now export QSP 1.9-compliant models directly into regulatory submission formats.

Unlike its predecessors that required local high-performance computing clusters, QSP 1.9 is cloud-native. It supports parallel simulations on AWS, Azure, and Google Cloud, making it accessible to small biotechs and academic labs. | Feature | QSP 1

Cause: Too many high-res images loaded without unloading.
Fix: Use UNPICT command after leaving a location. Also, compress images to 720p max.

  • Parameterization

  • Simulation and Virtual Populations

  • Optimization and Validation

  • Export for Regulatory Submission